Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs

(2013) David M. Eddy et al.   ANNALS OF INTERNAL MEDICINE

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects

(2011) Johannes A.N. Dorresteijn et al.   EUROPEAN HEART JOURNAL

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial

(2011) Jonathan C Hill et al.   LANCET

Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies

(2011) Y. K. Loke et al.   THORAX

Standards of Medical Care in Diabetes--2011

(2010)   DIABETES CARE

Lessons from the Mammography Wars

(2010) Kerianne H. Quanstrum et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group

(2010) Jeff J. Guo et al.   VALUE IN HEALTH

Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease

(2009) Sonal Singh et al.   ARCHIVES OF INTERNAL MEDICINE

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

(2009) Milo A Puhan et al.   BMC Medicine

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

The Primary and Secondary Prevention of Coronary Artery Disease

(2008) Richard C. Becker et al.   CHEST

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

(2008) James L. Rosenzweig et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Going from evidence to recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal